27/04/2015 | 11:26 AM Yield compression will continue as a meaningful influence on equity markets for the foreseeable future, Morningstar analysts say.
24/04/2015 | 9:11 AM Our most-vetted, highest conviction ideas.
20/04/2015 | 9:56 AM MYOB's indicative price range looks reasonable but the bookbuild process increases risks for retail investors, Morningstar analysts say in their pre-IPO report.
30/03/2015 | 10:30 AM As part of a global review Morningstar has reassessed the moat sources of the four major Australian banks, while still maintaining their wide-moat ratings.
30/03/2015 | 10:06 AM While sentiment towards Crown is fragile and negative news flow shows no signs of easing, the long-term backdrop in Macau is favourable as the region transitions to a more sustainable business model.
30/03/2015 | 9:18 AM Despite a slump in the company's share price, Morningstar doesn't believe disappointing results from a recent clinical trial are disastrous for the Sirtex Medical's prospects.
10/03/2015 | 9:17 AM This well-known Australian law firm ticks all the boxes, having a competitive advantage, a growth strategy and a strong management team.
6/02/2015 | 10:57 AM Following a thorough review of its valuation methodology, Morningstar will be implementing improvements within its global coverage universe of around 1,400 companies in 2015.
4/02/2015 | 8:23 AM Morningstar expects the global plasma market to grow at 5 per cent over the next five years, with higher growth for the top three players including Australia's CSL.
19/12/2014 | 9:15 AM The outlook for the year ahead is still positive but there is no room for complacency, according to Morningstar's Peter Warnes.
23/12/2014 | 9:15 AM
19/12/2014 | 9:15 AM Our most-vetted, highest conviction ideas.
5/12/2014 | 9:15 AM Morningstar's Mark Taylor explores the source of BHP's dividend reliability, its track record of returns to shareholders, while also stress-testing distribution forecasts in an uncertain world.
2/12/2014 | 9:15 AM A clear differentiation strategy has positioned ResMed as one of two globally dominant players in the sleep apnea arena, Morningstar's Chris Kallos says.
21/11/2014 | 9:15 AM Key-person risk often overshadows Platinum's great execution in bolstering the business's strengths and rewarding shareholders.
17/11/2014 | 9:15 AM The demise of small resources is improving diversification in the small-cap index, according to Morningstar analysts.
11/11/2014 | 9:15 AM In this addendum, Morningstar provides guidance as to which moat-rated company suits which strategy or portfolio segment.
3/11/2014 | 9:15 AM A penchant for innovation, strong management and its patent-protected product line grant James Hardie the cost advantage that forms the lynchpin of its narrow economic moat.
3/11/2014 | 9:15 AM Morningstar brings you the full list of companies that have been assigned economic moats in its Australian and New Zealand coverage of some 230 companies.
31/10/2014 | 9:15 AM While cost-out strategies resulted in solid fiscal 2014 earnings, pain in fiscal 2015 is needed to ensure gain in the years that follow.
31/10/2014 | 9:15 AM Investing in quality is likely to be the wisest course of action in a difficult consumer environment, Morningstar analysts say.
31/10/2014 | 9:15 AM Financial services companies are set to deliver strong profit and dividend growth, but potential for higher interest rates is weighing on the sector.
31/10/2014 | 9:15 AM Burgeoning supply and peak steel consumption in China will mark the end of the "golden age" of Australian iron ore, Morningstar analysts say.
31/10/2014 | 9:15 AM New Zealand's economic outlook is positive but this is largely reflected in market valuations, Morningstar analysts say.
31/10/2014 | 9:15 AM Opportunities have emerged in the Australian share market following a 7 per cent fall in the S&P/ASX 200 Index in September, Morningstar analysts say.
24/10/2014 | 9:15 AM In retail, the lack of moats means strong stewardship can make an immense difference to the fate of a company, as Morningstar analysts illustrate.
24/10/2014 | 9:15 AM Stewardship becomes even more critical when sorting the wheat from the chaff in the Australian retail industry, Morningstar analysts say.
23/10/2014 | 9:15 AM Medibank provides an opportunity to invest in Australia's largest private health insurer at a fair price or better, depending on the price set in the institutional bookbuild, Morningstar analysts say in this IPO report.
22/10/2014 | 9:15 AM Iron-ore prices will get worse before they get better and the recent decline in prices marks the early stages of a cyclical downturn for the industry, Morningstar analysts say.
15/10/2014 | 9:15 AM Morningstar provides its monthly Best Stock Ideas update, which features its most-vetted, highest-quality investment ideas trading at attractive prices.
26/09/2014 | 9:15 AM The float of the health insurer marks Australia's biggest IPO in several years and Morningstar gives investors an idea of what to expect in terms of the company's financial outlook, moat rating and its place within a portfolio.
19/09/2014 | 9:15 AM Growing demand and depleting wild supply could be a potent mix for sandalwood grower TFS Corporation, Morningstar analysts say.